4//SEC Filing
Mano Michael 4
Accession 0000950170-24-007589
CIK 0001503802other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 6:53 PM ET
Size
5.1 KB
Accession
0000950170-24-007589
Insider Transaction Report
Form 4
Mano Michael
SVP, General Counsel&Secretary
Transactions
- Award
Common Stock
2024-01-24+9,167→ 151,401 total
Footnotes (1)
- [F1]Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units ("PSUs") granted in February 2023 that have been earned based on the level of achievement of a certain clinical milestone, as certified by the issuer's compensation committee on January 24, 2024. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs will vest on February 28, 2024, the first anniversary of the grant date, subject to continued employment through such vesting date.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001837741
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 6:53 PM ET
- Size
- 5.1 KB